[{"address1": "444 West Lake Street", "address2": "Suite 1700", "city": "Chicago", "state": "IL", "zip": "60606", "country": "United States", "phone": "312 416 8592", "website": "https://www.MAIABiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vlad  Vitoc M.B.A., M.D.", "age": 52, "title": "Co-Founder, President, CEO & Chairman of the Board of Directors", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 715550, "exercisedValue": 0, "unexercisedValue": 3248211}, {"maxAge": 1, "name": "Dr. Sergei M. Gryaznov Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 524769, "exercisedValue": 0, "unexercisedValue": 1457995}, {"maxAge": 1, "name": "Mr. Jeffrey C. Himmelreich", "title": "Head of Finance", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Linda  Moreira", "title": "Company Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.35, "dayLow": 1.3, "dayHigh": 1.495, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.35, "regularMarketDayLow": 1.3, "regularMarketDayHigh": 1.495, "forwardPE": -0.93037975, "volume": 216323, "regularMarketVolume": 216323, "averageVolume": 419798, "averageVolume10days": 742920, "averageDailyVolume10Day": 742920, "bidSize": 800, "askSize": 1000, "marketCap": 24936786, "fiftyTwoWeekLow": 0.82, "fiftyTwoWeekHigh": 5.22, "fiftyDayAverage": 1.1723, "twoHundredDayAverage": 1.974915, "currency": "USD", "enterpriseValue": 14789274, "floatShares": 10016830, "sharesOutstanding": 16963800, "sharesShort": 268376, "sharesShortPriorMonth": 43143, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.015800001, "heldPercentInsiders": 0.24365, "heldPercentInstitutions": 0.018509999, "shortRatio": 0.87, "shortPercentOfFloat": 0.0195, "impliedSharesOutstanding": 16963800, "bookValue": 0.2, "priceToBook": 7.35, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -17661980, "trailingEps": -1.44, "forwardEps": -1.58, "52WeekChange": -0.71215355, "SandP52WeekChange": 0.20883334, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "MAIA", "underlyingSymbol": "MAIA", "shortName": "MAIA Biotechnology, Inc.", "longName": "MAIA Biotechnology, Inc.", "firstTradeDateEpochUtc": 1659015000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "0f42043f-a188-3808-9a57-e38f76c4260b", "messageBoardId": "finmb_631239285", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.47, "targetHighPrice": 14.0, "targetLowPrice": 11.25, "targetMeanPrice": 12.63, "targetMedianPrice": 12.63, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 6104587, "totalCashPerShare": 0.429, "quickRatio": 1.499, "currentRatio": 1.598, "returnOnAssets": -1.03285, "returnOnEquity": -2.43803, "freeCashflow": -7159628, "operatingCashflow": -11587905, "financialCurrency": "USD", "trailingPegRatio": null}]